Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection - Test2 - elhamkhani - TriplyDB

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

http://www.wikidata.org/entity/Q28252518

about

Glycans, galectins, and HIV-1 infection Galectin-1 exerts inhibitory effects during DENV-1 infection Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages Engineering galectin-glycan interactions for immunotherapy and immunomodulation Multivalent glycoconjugate syntheses and applications using aromatic scaffolds.Galectin-1 inhibitors and their potential therapeutic applications: a patent review.Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.Lactose Binding Induces Opposing Dynamics Changes in Human Galectins Revealed by NMR-Based Hydrogen-Deuterium Exchange.Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells.Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion

P2860

Q28265115-4D71AC5D-ED0D-443D-843D-8C67EE8711A2 Q28544937-AB21A63C-402A-4D96-ACCE-F78478924EB2 Q36166289-558AA273-56FA-4C0D-8176-9BB157E7F6F2 Q37107168-137ED562-B931-4DFD-B2C4-8FBF7F1188C9 Q38080745-C3524C03-F0A0-4DA2-962F-B0555644B42E Q38763827-B0C54E34-9C14-4097-83AB-560F2DE81741 Q39061268-703B703C-B36F-479D-90AA-BA9D5D8E79BC Q47302234-531DCC09-F498-4942-95F1-F3015FF832DA Q47946450-E7178B55-5AEE-4163-B548-0408404E39DB Q48334078-3B5B8CD3-E26A-460D-98CF-6EC18F21461F Q57910094-BBDB690B-191C-4F0B-846C-D8453FC31817

P2860

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

http://www.wikidata.org/entity/Q28252518

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@ast

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@en

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@nl

type

label

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@ast

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@en

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@nl

prefLabel

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@ast

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@en

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@nl

P1433

Q28252518-6DD7E3AC-0E6B-4089-AA93-AB7FA1EBE638

P1476

Q28252518-96163937-B764-4375-81BF-011FE3517A54

P2093

Q28252518-38237C7F-536B-41E2-A4C0-600276B88F98

Q28252518-47518013-C650-4D56-9E2F-99F32572AC59

Q28252518-877570A2-9E01-4486-8A20-0B1F375640C9

Q28252518-8DEC6D34-E974-4ACF-961B-65E84F541CAA

Q28252518-AB012C43-F2F2-4FF2-A442-85B301EBD0D8

Q28252518-FFBA75CC-BF66-4167-9235-2941396AF8DB

P2860

Q28252518-0B7A82D2-748B-4AEA-8103-22222D2747CF

Q28252518-15FBBE25-3323-47B0-AB42-64EFD2DC5E2C

Q28252518-1E57FE98-0BBB-4244-8C6C-53FABD5504BC

Q28252518-2101940A-41CE-45FB-AF09-1F9AAF534689

Q28252518-2BD18730-8B04-4D6A-8FFB-210F97FDCF8A

Q28252518-2EEBEC9D-74A8-49EC-B40E-E403DB271549

Q28252518-30ADA8BD-B356-48E9-A844-EC10CA1F64CC

Q28252518-30B85E6A-4595-41BB-8A8D-F9C16B364B55

Q28252518-32B703B1-B0A6-4EF7-93AC-E1C80BFA6398

Q28252518-39BF3CA8-E91A-4682-B86B-8B3DBDE1C276

P304

Q28252518-E88FBA5C-C85B-4C28-9CAF-5FB5F29550D7

P31

Q28252518-BEE31ADA-9750-422B-92F5-5F5524C49850

P356

Q28252518-52DC489E-4191-47A6-8038-FCF567D45E4E

P407

Q28252518-2B4B146A-F999-4F4F-ADFD-3CD840411188

P433

Q28252518-6862C4D2-CE8F-4C44-BCB1-AF229D104057

P478

Q28252518-5361217E-10AC-43FB-A911-C6E484F28473

P50

Q28252518-BFDAA112-1357-4772-BB53-3D93628908E0

P577

Q28252518-54A28D07-FD46-43A0-93EB-536F91666D10

P5875

Q28252518-7C96F1C1-DD44-4C23-B09C-DFF5E7F9FA86

P698

Q28252518-E4A01752-A87E-4ADF-ABFF-B474E0370320

P921

Q28252518-6AEFA1B4-6BED-40E2-9561-5F891D3AB104

P932

Q28252518-E0A9914A-2BCD-4448-BD29-BB685D89F375

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

@en

P2093

Christian St-Pierre

http://www.w3.org/2001/XMLSchema#string

Denis Giguère

http://www.w3.org/2001/XMLSchema#string

Michel J Tremblay

http://www.w3.org/2001/XMLSchema#string

Reiko Ohtake

http://www.w3.org/2001/XMLSchema#string

René Roy

http://www.w3.org/2001/XMLSchema#string

Sachiko Sato

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 gene expression: lessons from provirus and non-integrated DNA

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR

Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

The HIV Env-mediated fusion reaction

P304

154-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.05595-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51782068

http://www.w3.org/2001/XMLSchema#string

P698

22064534

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3256073

http://www.w3.org/2001/XMLSchema#string